Literature DB >> 15980948

Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy.

Norihiko Goto1, Yoshihiro Tominaga, Susumu Matsuoka, Tetsuhiko Sato, Akio Katayama, Toshihito Haba, Kazuharu Uchida.   

Abstract

BACKGROUND: The frequency and prognosis of dilated cardiomyopathy (DCM) caused by secondary hyperparathyroidism (2 degrees HPT) is not known. The purpose of this study was to determine the morbidity of DCM caused by 2 degrees HPT and the efficacy of parathyroidectomy (PTx) in chronic dialysis patients with advanced 2 degrees HPT was analyzed prospectively.
METHODS: Between November 2000 and January 2003, 237 dialysis patients who underwent total PTx with forearm autograft at our department were enrolled in this study. Cardiac complications that existed before PTx were examined. Ten patients (4%) had DCM without valvular disease (VD) or ischemic heart disease (IHD). In these 10 patients with DCM before operation, we estimated left ventricular (LV) function at 6 months after PTx, according to echocardiography findings and clinical symptoms.
RESULTS: Six months after PTx, left ventricular ejection fraction (LVEF) in these 10 patients was significantly improved, from 31.0 +/- 9.8% before PTx, to 56.8 +/- 13.5% (P = 0.0003), and left ventricular end-diastolic dimension (LVDd) was reduced, from 59.8 +/- 9.7 mm to 46.3 +/- 7.0 mm (P = 0.0014). The symptoms due to DCM and the fall of blood pressure that had occurred during dialysis were clearly improved after PTx.
CONCLUSIONS: Advanced 2 degrees HPT can influence LV function, and in patients who suffered from DCM, LV function was dramatically improved by PTx. PTx should be performed immediately in patients with DCM caused by 2 degrees HPT.

Entities:  

Mesh:

Year:  2005        PMID: 15980948     DOI: 10.1007/s10157-005-0351-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  16 in total

Review 1.  Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology.

Authors:  V A Zammit
Journal:  Prog Lipid Res       Date:  1999-05       Impact factor: 16.195

Review 2.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

Authors:  J R Neely; H E Morgan
Journal:  Annu Rev Physiol       Date:  1974       Impact factor: 19.318

3.  Uremic cardiomyopathy: an inadequate left ventricular hypertrophy.

Authors:  G M London; F Fabiani; S J Marchais; M C de Vernejoul; A P Guerin; M E Safar; F Metivier; F Llach
Journal:  Kidney Int       Date:  1987-04       Impact factor: 10.612

Review 4.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

5.  Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.

Authors:  Santhi K Ganesh; Austin G Stack; Nathan W Levin; Tempie Hulbert-Shearon; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

6.  Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.

Authors:  Chun-Liang Lin; Cheng-Chieh Hung; Cheng-Ta Yang; Chiu-Ching Huang
Journal:  Ren Fail       Date:  2004-05       Impact factor: 2.606

7.  Effect of parathyroid hormone on myocardial energy metabolism in the rat.

Authors:  R Baczynski; S G Massry; R Kohan; M Magott; Y Saglikes; N Brautbar
Journal:  Kidney Int       Date:  1985-05       Impact factor: 10.612

8.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

Authors:  J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

9.  A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

Authors:  K Amann; E Ritz; G Wiest; G Klaus; G Mall
Journal:  J Am Soc Nephrol       Date:  1994-04       Impact factor: 10.121

10.  Impact of renal transplantation on uremic cardiomyopathy.

Authors:  P S Parfrey; J D Harnett; R N Foley; G M Kent; D C Murray; P E Barre; R D Guttmann
Journal:  Transplantation       Date:  1995-11-15       Impact factor: 4.939

View more
  8 in total

1.  Is three-gland-or-less parathyroidectomy a clinical failure for secondary hyperparathyroidism?

Authors:  Tolga Özmen; Manuk Manukyan; Semiha Şen; Arzu Kahveci; Cumhur Yeğen; Bahadır Mahmut Güllüoğlu
Journal:  Ulus Cerrahi Derg       Date:  2014-12-01

2.  Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.

Authors:  Masahiro Yamamoto; Hiroaki Ogata; Masahide Mizobuchi; Noriyo Yoshida; Chiaki Kumata-Maeta; Fumihiko Koiwa; Kanji Shishido; Eriko Kinugasa
Journal:  Clin Exp Nephrol       Date:  2011-10-20       Impact factor: 2.801

3.  Increasing Age Hinders the Decline in B-Type Natriuretic Peptide Following Parathyroidectomy in Dialysis Patients.

Authors:  Tun-Pang Chu; Po-Sheng Yang; Jie-Jen Lee; Chih-Jen Wu; Shih-Ping Cheng
Journal:  In Vivo       Date:  2019 Sep-Oct       Impact factor: 2.155

4.  Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism.

Authors:  Elif Hindié; Paolo Zanotti-Fregonara; Pierre-Alexandre Just; Emile Sarfati; Didier Mellière; Marie-Elisabeth Toubert; Jean-Luc Moretti; Christian Jeanguillaume; Isabelle Keller; Pablo Ureña-Torres
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-28       Impact factor: 9.236

Review 5.  Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Authors:  Yoshihiro Tominaga; Susumu Matsuoka; Nobuaki Uno
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

6.  The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control.

Authors:  Mario Cozzolino; Florjan Mehmeti; Paola Ciceri; Elisa Volpi; Andrea Stucchi; Irene Brenna; Daniele Cusi
Journal:  Int J Nephrol       Date:  2011-03-29

7.  Current status of parathyroidectomy for secondary hyperparathyroidism in Japan.

Authors:  Yoshihiro Tominaga
Journal:  NDT Plus       Date:  2008-08

8.  Impact of parathyroidectomy on left ventricular function in end stage renal disease patients.

Authors:  Shaohua Chen; Kaixiang Sheng; Ying Shen; Hua Jiang; Xin Lei; Lihui Qu; Chunping Xu; Jianghua Chen; Ping Zhang
Journal:  BMC Nephrol       Date:  2020-11-13       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.